Nezar Falluji, MD

Obstructive peripheral artery disease (PAD) manifests itself with intermittent claudication (affecting 20 to 40 million individuals worldwide), which is described as exertional lower extremity pains, and in more advanced stages with critical limb ischemia and acute or chronic limb ischemia. Irrespective of presentation, patients with PAD are at increased risk for adverse cardiovascular (CV) events. Therefore, risk factor modification is the cornerstone of the management of PAD.